79th World Health Assembly (WHA79): Reform of the global health architecture and the UN80 Initiative
On 21 May 2026, IFPMA delivered a statement on the reform of the global health architecture and the UN80 Initiative at the 79th session of the World Health Assembly.
IFPMA believes a stronger global health architecture should foster innovation, strengthen health systems so innovations reach people, and forge partnerships to advance health globally.
For the joint process to succeed, three safeguards are essential.
- First, it should clarify mandates, comparative advantages and decision pathways across institutions, including how recommendations affecting organizations beyond WHO would be considered by their own governing bodies.
- Second, it should ensure balanced participation, with the private sector included alongside civil society in core structures, including the joint task force and any time-limited working groups, where relevant.
- Third, product innovation and access should remain within WHO’s constitutional and Member State-mandated functions, and should not drift into IP, licensing, pricing, procurement, manufacturing, or supply decisions.
IFPMA stands ready to contribute.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
